ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      ENTOD meets Drug Controller General of India, issues clarificatio

ENTOD meets Drug Controller General of India, issues clarificatio

Mumbai-based ENTOD Pharmaceuticals met with the Drug Controller General of India (DCGI) earlier this week to address...

      
      Entod pharma to move court against DCGI's order

Entod pharma to move court against DCGI's order

The drug regulator suspended permission, citing the company's failure to respond to the queries on the product for...

      
      Drug regulator suspends product PresVu over unauthorised promotio

Drug regulator suspends product PresVu over unauthorised promotio

The Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod...


      
      Entod Pharmaceuticals PresVu eye drops

Entod Pharmaceuticals PresVu eye drops

The ENTOD Pharmaceuticals claiming PresVU eye drops approved by DCGI offering spectacular treatment for...


      
      New initiative by the DCGI to boost ease of doing business

New initiative by the DCGI to boost ease of doing business

In a recent public notice, the Drug Controller General of India (DCGI) announced a new initiative aimed at enhancing...

      
      DCGI bans charges, except supply, processing costs on blood units

DCGI bans charges, except supply, processing costs on blood units

The Drugs Controller General of India (DCGI) has waived all charges except processing costs on blood units.


      
      Glenmark is first to launch Biosimilar of Liraglutide in India

Glenmark is first to launch Biosimilar of Liraglutide in India

Mumbai (Maharashtra) [India], January 3: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global...

      
      NHRC sends notice to Delhi Chief Secy, DCGI over epilepsy drug

NHRC sends notice to Delhi Chief Secy, DCGI over epilepsy drug

The National Human Rights Commission (NHRC) sent notices to the Delhi Chief Secretary, Drugs Controller General of...

      
      Mandaviya directs regulator to act against spurious drugs maker

Mandaviya directs regulator to act against spurious drugs maker

Union Health Minister Mansukh Mandaviya has directed the Drugs Controller General of India (DCGI) to take stringent...

      
      Intas launches DCGI-approved Tofacitinib Topical (JAKi)

Intas launches DCGI-approved Tofacitinib Topical (JAKi)

Ahmedabad (Gujarat) [India], June 29: Intas Pharmaceuticals Ltd., one of India's leading pharmaceutical companies...

      
      Booster vaccine for Omicron variant gets emergency use approval

Booster vaccine for Omicron variant gets emergency use approval

The mRNA-based booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of...

      
      AstraZeneca receives nod to import breast cancer treating drug

AstraZeneca receives nod to import breast cancer treating drug

AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has...

Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.